Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Current Pharmaceutical Biotechnology
|
December 16, 2006
Bortezomib as an antitumor agent
A M Roccaro, T Hideshima, P G Richardson, et al.
Leukemia
|
May 11, 2017
KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival
H Ohguchi, T Harada, M Sagawa, et al.
Blood
|
July 27, 2001
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
C S Mitsiades, S P Treon, N Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
T Hideshima, D Chauhan, G Teoh, et al.
Leukemia
|
January 17, 2003
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo
S Lentzsch, R LeBlanc, K Podar, et al.
Leukemia
|
November 5, 2011
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway
K Sukhdeo, M Mani, T Hideshima, et al.
Leukemia
|
May 12, 2017
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
T Harada, H Ohguchi, Y Grondin, et al.
Leukemia
|
November 25, 2010
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells
W Song, Y-T Tai, Z Tian, et al.
Journal of Immunological Methods
|
February 17, 2000
Isolation and characterization of human multiple myeloma cell enriched populations
Y T Tai, G Teoh, Y Shima, et al.
Oncogene
|
October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
D Chauhan, M Velankar, M Brahmandam, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Current Pharmaceutical Biotechnology
|
December 16, 2006
Bortezomib as an antitumor agent
A M Roccaro, T Hideshima, P G Richardson, et al.
Leukemia
|
May 11, 2017
KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival
H Ohguchi, T Harada, M Sagawa, et al.
Blood
|
July 27, 2001
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
C S Mitsiades, S P Treon, N Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
T Hideshima, D Chauhan, G Teoh, et al.
Leukemia
|
January 17, 2003
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo
S Lentzsch, R LeBlanc, K Podar, et al.
Leukemia
|
November 5, 2011
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway
K Sukhdeo, M Mani, T Hideshima, et al.
Leukemia
|
May 12, 2017
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
T Harada, H Ohguchi, Y Grondin, et al.
Leukemia
|
November 25, 2010
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells
W Song, Y-T Tai, Z Tian, et al.
Journal of Immunological Methods
|
February 17, 2000
Isolation and characterization of human multiple myeloma cell enriched populations
Y T Tai, G Teoh, Y Shima, et al.
Oncogene
|
October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma
D Chauhan, M Velankar, M Brahmandam, et al.
Page
of 9